Military-Relevant Infectious Diseases Endemic to Kenya: Epidemiology, Immunology, Pathophysiology, Treatment, and Prevention

摘要

The mission of USAMRU-K is to develop and test improved products for the diagnosis, treatment and prevention of infectious disease threats to deployed service members. Surveillance activities are also conducted to identify and develop response strategies for global emerging infections with a potential to impact readiness, mission accomplishment, or homeland security. These activities are undertaken in research laboratories and field stations in locations where malaria, HIV/AlDS, leishmaniasis, West Nile virus, enteric pathogens, dengue, and other military/relevant infectious diseases are prevalent and their transmission rates are high. USAMRU-K also played a role in the execution of the President's Emergency Plan for AIDS Relief, a $15 billion program to provide prevention and Care programs to HIV/AlDS victims in Africa, Malaria drug and vaccine trials were executed in Kombewa to provide valuable information that will inform protective strategies for the war fighter. During this three year Cooperative Agreement, USAMRU-K's ability to successfully execute clinical studies has been enhanced by the construction of over 57,000 sq ft of additional space for state-of-the-art laboratories and support activities. The co-location of these modern clinical research facilities within high disease endemicity areas will position USAMRU-K as a preferred site for future vaccine, drug, and other interventional trials.